Abstract Details

Title Dalfampridine Treatment in Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Topic Neuro-ophthalmology/Neuro-otology

Presentation(s) P5 - (-)

Poster/Presentation
Number 202

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Mark L. Moster, MD, FAAN (Neuro-Ophthalmology -Wills Eye Hospital) PRESENTER	Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Gensight . Dr. Moster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viridian. Dr. Moster has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kilcoyne and Nesbitt.
Robert C. Sergott, MD (Wills Eye Hospital)	Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Sergott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
	No disclosure on file